ArticleBMC microbiology2026
Inoculation of Bacillus cabrialesii modulates plant growth and wilt disease of chickpea cultivars pre-challenged with Fusarium oxysporum f. sp. ciceris.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundBacillus cabrialesii, a plant growth-promoting (PGP) and biocontrol bacterium, was first reported in Mexico in 2018. This study evaluates the PGP and antagonistic potential of two B. cabrialesii strains, IS-10 and BATS-13, isolated from the chickpea rhizospheric soils of Chhattisgarh, India. It also assesses the impact of strain IS-10 on the growth, yield, and disease resistance of chickpea cultivars under Fusarium wilt stress.
methodsPGP traits and antifungal activity of the isolates were characterized in vitro, including biosurfactant production. The biosurfactant nature was analyzed using thin-layer chromatography (TLC) and ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). Strain IS-10 was used for seed bacterization in sterile soil amended with 0.2% vermicompost and 0.02% gum acacia, in the presence or absence of Fusarium oxysporum f. sp. ciceris (FOC), to evaluate its effects on plant growth and disease suppression in two chickpea cultivars, Vaibhav and JG-62.
resultsBoth strains demonstrated multiple PGP attributes and inhibited FOC growth in vitro. TLC revealed the presence of lipids and peptides in the crude biosurfactant, and further UPLC-MS/MS analyses confirmed the presence of surfactin and fengycin. In the pot trials, strain IS-10 treatment significantly improved plant performance. In pathogen-free conditions, strain IS-10 increased straw yield by 39.17% (Vaibhav) and 39.47% (JG-62), and grain yield by 46.8% (Vaibhav) and 50.32% (JG-62), respectively, over untreated controls. Under FOC challenge conditions, strain IS-10 reduced disease incidence by 20.80% (Vaibhav) and 26.85% (JG-62), while enhancing straw yield by 53.92% and 36.6%, and grain yield by 57.14% and 50.81%, respectively, compared to pathogen controls.
conclusionsB. cabrialesii IS-10 possesses significant PGP and biocontrol traits, including production of antifungal lipopeptides. Its application enhances chickpea growth and yield and mitigates the effects of Fusarium wilt, highlighting its potential as a bioinoculant for sustainable chickpea cultivation under both healthy and pathogen-infested conditions in the state of Chhattisgarh, India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.